Brussels, Belgium

Olivier De Backer

This inventor holds 2 USPTO granted patents. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 2003-2009.


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2003-2009

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Olivier De Backer: Innovator in Cancer Research

Introduction

Olivier De Backer is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research through his innovative work. With a total of two patents to his name, De Backer is recognized for his advancements in understanding the GAGE family of proteins.

Latest Patents

De Backer's latest patents include "Isolated GAGE-7B and 8 proteins" and "Isolated, truncated nucleic acid which are members of the GAGE." These inventions relate to new members of the GAGE family, specifically GAGE-7B and GAGE-8. There are notable differences between these two molecules and the previously described members of the GAGE family at the genomic DNA, complementary DNA, and amino acid levels.

Career Highlights

Olivier De Backer is affiliated with the Ludwig Institute for Cancer Research Limited. His work at this prestigious institution has allowed him to focus on groundbreaking research that has the potential to impact cancer treatment and understanding.

Collaborations

De Backer has collaborated with esteemed colleagues such as Benoit Van Den Eynde and Thierry R Boon-Falleur. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Olivier De Backer is a prominent figure in cancer research, with innovative patents that enhance our understanding of the GAGE family of proteins. His contributions are vital to the ongoing fight against cancer and showcase the importance of research and collaboration in scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…